fda curbs
Slash Heavy Penalties 50% With Prescription Weight Loss Safeguards
You must redesign your compounding workflow to meet the FDA’s new restrictions on bulk GLP-1 drugs, limit batch sizes, shift to manufacturer-direct sourcing, and add real-time compliance monitoring before the deadline. Failure to adapt can trigger 50% higher penalties. Within 90 days the FDA expects full compliance with the